Epirubicin approved for breast cancer treatment

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1999年 / 56卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2177 / 2177
页数：1
相关论文
共 50 条
  • [31] Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer
    Abrahamova, J
    Wagnerova, M
    Kubala, E
    Malec, V
    Simova, E
    Sirakova, I
    Pavlikova, E
    Machova, D
    Kocak, I
    Pavlikova, I
    Tuma, P
    Prausova, J
    Kroslakova, D
    Van Praagh, I
    ONCOLOGIST, 2001, 6 (04): : 347 - 352
  • [32] A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer
    Esteban, E
    de Sande, G
    Puertas, J
    Fra, J
    Palacio, I
    Vieitez, JM
    Fernández, JL
    Muñiz, I
    Modollel, A
    Carrasco, J
    Sala, M
    Lacave, AJ
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (02) : 127 - 133
  • [33] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
    Ron, IG
    Sarid, DL
    Wigler, N
    Inbar, MJ
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
  • [34] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
    Sarid, David
    Ron, Ilan G.
    Sperber, Fani
    Stadler, Yona
    Kahan, Perry
    Kovner, Felix
    Ben-Yosef, Rami
    Marmor, Sylvia
    Grinberg, Yulia
    Maimon, Natalie
    Weinstein, Juliana
    Yaal-Hahoshen, Neora
    CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
  • [35] Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
    Jamieson, David
    Lee, Jo
    Cresti, Nicola
    Jackson, Rosanna
    Griffin, Melanie
    Sludden, Julieanne
    Verrill, Mark
    Boddy, Alan V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 667 - 674
  • [36] Paclitaxel plus epirubicin in advanced breast cancer
    Conte, PF
    Gennari, A
    Salvadori, B
    Pazzagli, I
    Bengala, C
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 40 - 44
  • [37] EPIRUBICIN CARDIOTOXICITY ON BREAST CANCER ADJUVANT SETTING
    Faustino, I.
    Sousa, S.
    Rego, S.
    Couto, R.
    Mauricio, M. J.
    Pereira, D.
    Afonso, N.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 94 - 94
  • [38] Paclitaxel: Epirubicin in metastatic breast cancer - a review
    Razis, ED
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 593 - 598
  • [39] Approved Agents for Metastatic Breast Cancer
    Fornier, Monica N.
    SEMINARS IN ONCOLOGY, 2011, 38 (03) : S3 - S10
  • [40] Eribulin approved for advanced breast cancer
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (01) : 6 - 6
12345